Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anu taila is a classical Ayurvedic polyherbal medicated oil used primarily as an intranasal preparation in nasya therapy. It is an oil-based formulation prepared with sesame oil as the base and, according to the cited standardization literature, contains more than 25 herbal ingredients plus goat milk. Published contemporary literature describes its use mainly for upper airway and neurologic-related Ayurvedic indications, and recent exploratory work has evaluated it for allergic rhinitis, COVID-19 prophylaxis, and other respiratory or neurophysiologic applications. Its mechanism is not defined in modern drug-target terms, but preclinical studies suggest broad local antifungal and host-modulatory effects, including delayed mucorale spore germination, reduction of fungal ergosterol biosynthesis, modulation of cAMP-PKA-associated reactive oxygen species in fungi, and enhancement of host TNF-alpha-associated immune responses. It is best characterized as a traditional multi-component intranasal herbal oil rather than a single-molecule pharmaceutical entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on anu taila.